Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_337
Snippet: Dogs were randomly assigned into two different treatment groups in a blinded fashion, for receiving anti-neoplastic drug (etoposide phosphate or F-14512). All dogs involved in the study followed the same protocol over a period of 8 weeks. The protocol consisted of four cycles of F14512 (0.075 mg/kg) or etoposide phosphate (100 mg/m 2 ) IV injections every 2 weeks with a 3-h injection once daily on 3 consecutive days. Shortterm response was assess.....
Document: Dogs were randomly assigned into two different treatment groups in a blinded fashion, for receiving anti-neoplastic drug (etoposide phosphate or F-14512). All dogs involved in the study followed the same protocol over a period of 8 weeks. The protocol consisted of four cycles of F14512 (0.075 mg/kg) or etoposide phosphate (100 mg/m 2 ) IV injections every 2 weeks with a 3-h injection once daily on 3 consecutive days. Shortterm response was assessed by repeating complete staging at day 62, according to the RECIST criteria published for peripheral nodal lymphoma in dogs. Dogs were then followed every month until relapse. In case of relapse, a complementary CHOP-based chemotherapy protocol was proposed to the dog's owner.
Search related documents:
Co phrase search for related documents- blinded fashion and treatment group: 1, 2, 3
- consecutive day and treatment group: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date